(IMAGE) Deep Longevity Ltd Caption randomized clinical trial for prevention of COVID-19 by rapamycin would likely involve transient rapamycin treatment with rapamycin in older (selectively enrolled if estimated biological age exceeds their chronological age) adults at high risk for COVID-19 complications over a period of several weeks. Credit Deep Longevity Limited Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.